17 results
10-K
2023 FY
EX-10.7
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
10-K
2023 FY
EX-10.9
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
10-K
2023 FY
EX-10.8
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
10-K
2023 FY
EX-10.4
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
10-K
2023 FY
EX-10.10
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
F-1
EX-10.5
k7hlp amw
19 Dec 22
Registration statement (foreign)
6:22pm
F-1
EX-10.15
i0lm7 lp994qmu
19 Dec 22
Registration statement (foreign)
6:22pm
F-1
EX-10.13
lcwan36x c5d5
19 Dec 22
Registration statement (foreign)
6:22pm
6-K
EX-10.1
6u9x 26jfrdvezwmzb73
19 Dec 22
NewAmsterdam Announces Appointment of David Topper as Chief Financial Officer
4:23pm
F-4/A
EX-10.13
a7xj 3datuipu6a
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
F-4/A
EX-10.14
pts35g0p
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
F-4/A
EX-10.7
h2dtkttypcu2ut6i5
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
F-4/A
EX-10.11
nfreek jn
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4/A
EX-10.10
uvb7uewm
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4/A
EX-10.12
hpe3xu2
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4/A
EX-10.9
pzrrooj 0q5g
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4
EX-10.8
9xhmpvf
4 Aug 22
Registration of securities (foreign)
8:02am
- Prev
- 1
- Next